|
|
Vol. 24.18 – 29 May, 2023
|
|
|
|
|
|
|
|
With the help of functional intravital imaging, scientists reported that interferon (IFN)-γ production but not perforin-mediated cytotoxicity was the dominant mechanism for tumor elimination by anti-CD19 CD4+ CAR T cells. [Nature Cancer]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Investigators presented an exploratory analysis evaluating the hematopoietic reconstitution kinetics, engraftment, and clonality in 13 pediatric Wiskott-Aldrich syndrome patients.
[Nature Communications]
|
|
|
|
|
|
A single adeno-associated virus-humanTMPRSS3 injection in Tmprss3A306T/A306T mice of an average age of 18.5 months led to the sustained rescue of the auditory function to a level similar to wild-type mice.
[Molecular Therapy]
|
|
|
|
|
|
Researchers showed that suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cells carrying the herpes simplex virus-thymidine kinase gene was safe in patients with recurrent glioblastoma multiforme.
[Journal Of Translational Medicine]
|
|
|
|
|
|
Investigators performed a preclinical study by transplanting human brain-derived-induced multipotent stem cells transcranially into post-stroke mouse brains six weeks after middle cerebral artery occlusion.
[Stem Cells Translational Medicine]
|
|
|
|
|
|
Germinal center B-cell-like diffuse large B-cell lymphoma cell line OCI-Ly1, and patient-derived xenografted mice were used as the CAR-T cell-resistant model.
[Cellular Oncology]
|
|
|
|
|
|
Scientists reported the development of a new BiTE with cytotoxic activity against CD22+ cells which could represent an alternate or complementary therapeutic option for B cell malignancies.
[Cancer Immunology Immunotherapy]
|
|
|
|
|
|
Female rats were assigned to either injection of saline, allogeneic-mesoangioblasts (MABs), autologous-MABs, or allogeneic-MABs transduced to stably expressed vascular endothelial growth factor (VEGF).
[Scientific Reports]
|
|
|
|
|
|
Investigators reported a single-center retrospective study of infectious complications following CAR-T cell therapy in 48 adult patients with relapsed and refractory B cell non-Hodgkin lymphoma. [Annals Of Hematology]
|
|
|
|
|
|
|
|
The authors review the most recent management strategies for Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. [International Journal Of Antimicrobial Agents]
|
|
|
|
|
|
|
|
Iovance Biotherapeutics, Inc. announced that the US FDA accepted its Biologics License Application for Lifileucel, a tumor-infiltrating lymphocyte therapy, for patients with advanced melanoma. [Iovance Biotherapeutics, Inc.]
|
|
|
|
|
|
|
|
June 5 – 8, 2023 Winston-Salem, North Carolina, United States
|
|
|
|
|
|
|
|
|
|
|
Vlaams Instituut voor Biotechnologie – Ghent, Belgium
|
|
|
|
|
|
|
Massachusetts Institute of Technology – Cambridge, Massachusetts, United States
|
|
|
|
|
|
|
Max Delbrück Center for Molecular Medicine – Berlin, Germany
|
|
|
|
|
|
|
Centre for Oncology and Immunology – Hong Kong, Hong Kong
|
|
|
|
|
|
|
Weill Cornell Medical College – New York, New York, United States |
|
|
|
|
|